PKC412
| PKC412 | |
|---|---|
| Term | PKC412 |
| Short definition | PKC412 - A drug used alone or with other anticancer drugs to treat adults with certain types of acute myeloid leukemia, mast cell leukemia, or systemic mastocytosis. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
PKC412 - A drug used alone or with other anticancer drugs to treat adults with certain types of acute myeloid leukemia, mast cell leukemia, or systemic mastocytosis. It is also being studied in the treatment of other types of cancer. PKC412 blocks certain proteins that can prevent cancer cells from growing and kill them. It can also prevent the growth of new blood vessels that tumors need to grow. PKC412 is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis agent. Also called midostaurin, N-benzoyl staurosporine and Rydapt
External links
- Medical encyclopedia article on PKC412
- Wikipedia's article - PKC412
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski